Skip to main content
Fig. 1 | BMC Endocrine Disorders

Fig. 1

From: Effects of semicarbazide-sensitive amine oxidase inhibitors on morphology of aorta and kidney in diabetic rats

Fig. 1

Inhibition of aortic SSAO activity exerted by AG and 2-BEA in vitro (n = 3). SSAO activity was measured by HPLC method using benzylamine as substrate. For assessment of inhibitory effect, SSAO was pre-incubated in the presence or absence of different concentrations of 2- BEA (a) or AG (b) before the addition of benzylamine. SSAO, semicarbazide-sensitive amine oxidase; AG, aminoguanidine; 2-BEA, 2-bromoethylamine

Back to article page